Whitepaper - Pharmaceutical Executive

ADVERTISEMENT

Whitepaper

The Paperless Future of Healthcare and Life Sciences

January 3, 2014

Download this whitepaper and discover how DocuSign?s eSignature solutions modernize life science organizations by eliminating paper and antiquated signature processes while meeting compliance requirements and reducing costs and errors.

Virtual Environments in a Pharmaceutical Marketplace

December 26, 2013

A comprehensive overview of how today?s pharmaceutical marketplace is quickly adopting virtual platform and webcasting technologies to effectively communicate, maximize resources and increase engagement with its customers.

Successful Strategic Partnering

December 1, 2013

This paper addresses how biopharmaceutical companies are turning to strategic outsourcing to address their business needs because these partnerships lower the cost of doing business, while increasing productivity and efficiency.

Connected Healthcare

March 31, 2014

Connected Healthcare: Adding new pharma brand value by unlocking outcomes measurement with mobile technology, behavior-change programs, compliance programs, and facilitated data exchange.

Risk-Based Monitoring: The Key to Optimizing Clinical Trials

December 20, 2013

Pharmaceutical firms and CROs continue to be challenged with meeting industry guidelines set by the FDA and ICH for risk-based monitoring of clinical trials. Read about how the use of centralized and proactive analytics is integral in planning a strategy going forward.

Multichannel: Insights for Measuring Effectiveness

October 14, 2013

This paper demonstrates how multichannel customer engagement strategy helps organizations succeed in a more complex, regulated and cost conscious market. Using on the results of a recently Cegedim Strategic Data study on sales rep detailing by channel effectiveness , this is the first in a series of whitepapers on the subject.

Applying Data to Improve Patient-Centric and Personalized Medicine

August 30, 2013

At the 10th Annual SAS Health Care & Life Sciences Executive Conference, SAS brought together great minds from across the industry – provider, pharma, payer and policy sectors – to discuss how data and analytics are advancing the triple aim of better care and improved health at a lower cost.

5-Minute Guide to Analytics in Pharmaceutical Emerging Markets

July 18, 2013

Over the next five years, two-thirds of pharmaceutical sales growth will come from emerging markets. While this presents enormous potential, how can organizations compete to capture new opportunities? It comes down to the data. Emerging markets present fertile ground for growth, but each must be understood to break into and capture potential.

Life-Cycle Marketing

July 10, 2013

Providing patient access solutions to pharmaceutical partners is no longer a one size fits all proposition. Life-cycle marketing addresses access strategies from a brands? pre-launch through patent expiry phases.

ADVERTISEMENT

Click here